Purpose.

This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites new or renewal (competing) applications for P30 Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers.

CCSGs support two types

credit:

How's Your Community Doing?
Check Out it's
Community Vital Signs

of cancer centers:
1) Comprehensive Cancer Centers, which demonstrate reasonable depth and breadth of research activities in each of three major areas -- laboratory, clinical, and population-based research -- and which have substantial transdisciplinary research that bridges these scientific areas; and 2) Cancer Centers, which are primarily focused on laboratory research, clinical research, population science research, or some combination of these components.

The purpose of both types of NCI-designated Cancer Centers is to capitalize on all institutional cancer research capabilities, integrating meritorious programs in laboratory, clinical, and population research into a single transdisciplinary research enterprise across all institutional boundaries.

Cancer Centers supported through the P30 grant mechanism are expected:
to serve as major sources of discovery of the nature of cancer and of development of more effective approaches to prevention, diagnosis, and therapy; to contribute significantly to the development of shared resources that support research; to collaborate and coordinate their research efforts with other NCI-funded programs and investigators; and to disseminate research findings for the benefit of the community.

Mechanism of Support.

This Funding Opportunity Announcement (FOA) will utilize the NIH center grant (P30) mechanism.

Funds Available and Anticipated Number of Awards.

Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.